PRODUIT COMPRENANT AU MOINS UNE SUBSTANCE INHIBITRICE DES NO SYNTHASES EN ASSOCIATION AVEC AU MOINS UNE SUBSTANCE INHIBITRICE DES PHOSPHOLIPASES A2

摘要

The invention concerns a product comprising at least a NO synthase inhibiting substance associated with at least a phospholipase A2 inhibiting substance, separately or combined, for simultaneous therapeutic use, separately or spread over time for treating pathologies in which nitrogen monoxide and/or phosplipases A2 are involved. The invention also concerns a pharmaceutical composition comprising, as active principle, at least a NO synthase inhibiting substance and at least a phospholipase A2 inhibiting substance, and optionally a pharmaceutically acceptable carrier.